z-logo
open-access-imgOpen Access
Radioprotectant Activity of 5‐Diethylsulfonamoylsalicylatocopper(II) in Gamma Irradiated Mice
Author(s) -
John A. Kuykendall,
H. E. Simmons,
Henry J. Irving,
Mark A. Wear,
Paul Sorenson,
Linda G. Tipton,
Kenchasha M. Maddox,
Elsie L. Williams,
Van Anh Pham-Tran,
Chassie Credit,
Israt L. Chowdhury,
Shaheen Khan,
J. Brooks Tipton,
William M. Willingham,
John R. J. Sorenson
Publication year - 1999
Publication title -
metal-based drugs
Language(s) - English
Resource type - Journals
ISSN - 0793-0291
DOI - 10.1155/mbd.1999.135
Subject(s) - irradiation , medicine , radiochemistry , chemistry , physics , nuclear physics
Survival and changes in mean body mass of whole-body irradiated mice were determined to examine the radioprotectant activity of 5-diethylsulfonamoylsalicylatocopper(II) [Cu(II) (5-DESS)]. One of four groups of 25 female C57BL/6 mice were treated subcutaneously (sc)with 0, 10, 20, 40, 60, 80, 100, or 120 mumol Cu(II)(5- DESS)/kg of body mass 3 hours before exposure to 8.0 Gy, gamma irradiation. In this paradigm, doses of Cu(II)(5- DESS) increased survival up to 92% above vehicle-treated control mice (P = 0.008). Mean body mass determinations revealed that mice treated with 80 to 120 mumol Cu(II)(5-DESS)/kg of body mass exhibited a smaller decrease in body mass than other complex-treated groups. These results support the hypothesis that Cu(II)(5-DESS) is an effective radioprotectant.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom